alt Hacker NewsWe finally found the first morbidity signal of GLP-1s (or lack thereof).
These are life changing drugs, but like plastic we'll see their effects in force within this generation:
> The longer time spent off GLP-1s, the greater the risk of major cardiovascular events—up to 22 percent for those who abstained for two years.
Replies
cthalupa • yesterday at 11:33 PM
You are misunderstanding the study (largely because the article heavily misrepresents it, would be my guess)
They do not see an increase against their pre-GLP1 baseline risk - they see a reversal of the cardioprotective benefits the drug provided while they were on it.
TaupeRanger • yesterday at 11:47 PM
You failed to understand the results of the study and quoted a passage that does not in any way support your assertion.
Doesn't it make sense that, if you were taking a drug that reduces morbidity, you'll get increased morbidity if you stop it?